C. Erem Et Al. , "Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hypothyroidism," ENDOCRINE , vol.35, no.1, pp.75-80, 2009
Erem, C. Et Al. 2009. Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hypothyroidism. ENDOCRINE , vol.35, no.1 , 75-80.
Erem, C., Ucuncu, Ö., YILMAZ, M., KOÇAK, M., Nuhoglu, İ., & Ersoz, H. Ö., (2009). Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hypothyroidism. ENDOCRINE , vol.35, no.1, 75-80.
Erem, CİHANGİR Et Al. "Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hypothyroidism," ENDOCRINE , vol.35, no.1, 75-80, 2009
Erem, CİHANGİR Et Al. "Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hypothyroidism." ENDOCRINE , vol.35, no.1, pp.75-80, 2009
Erem, C. Et Al. (2009) . "Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hypothyroidism." ENDOCRINE , vol.35, no.1, pp.75-80.
@article{article, author={CİHANGİR EREM Et Al. }, title={Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hypothyroidism}, journal={ENDOCRINE}, year=2009, pages={75-80} }